Pieter B. M. W. M. Timmermans
Hoofd Techniek/Wetenschap/O&O bij Kosan Biosciences, Inc.
Actieve functies van Pieter B. M. W. M. Timmermans
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Hoofd Techniek/Wetenschap/O&O | 01-01-2005 | - |
Loopbaan van Pieter B. M. W. M. Timmermans
Eerdere bekende functies van Pieter B. M. W. M. Timmermans
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 01-08-2004 | 01-01-2005 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01-01-1997 | 01-01-2004 |
| University of Amsterdam | Corporate Officer/Principal | - | - |
Opleiding van Pieter B. M. W. M. Timmermans
| University of Leiden | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Nederland | 3 |
Operationeel
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Health Technology |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
